Neuroprotection from NMDA excitotoxic lesion by Cu/Zn superoxide dismutase gene delivery to the postnatal rat brain by a modular protein vector

BackgroundSuperoxide mediated oxidative stress is a key neuropathologic mechanism in acute central nervous system injuries. We have analyzed the neuroprotective efficacy of the transient overexpression of antioxidant enzyme Cu/Zn Superoxide dismutase (SOD) after excitotoxic injury to the immature rat brain by using a recently constructed modular protein vector for non-viral gene delivery termed NLSCt. For this purpose, animals were injected with the NLSCt vector carrying the Cu/Zn SOD or the control GFP transgenes 2 hours after intracortical N-methyl-D-aspartate (NMDA) administration, and daily functional evaluation was performed. Moreover, 3 days after, lesion volume, neuronal degeneration and nitrotyrosine immunoreactivity were evaluated.ResultsOverexpression of Cu/Zn SOD transgene after NMDA administration showed improved functional outcome and a reduced lesion volume at 3 days post lesion. In secondary degenerative areas, increased neuronal survival as well as decreased numbers of degenerating neurons and nitrotyrosine immunoreactivity was seen. Interestingly, injection of the NLSCt vector carrying the control GFP transgene also displayed a significant neuroprotective effect but less pronounced.ConclusionWhen the appropriate levels of Cu/Zn SOD are expressed transiently after injury using the non-viral modular protein vector NLSCt a neuroprotective effect is seen. Thus recombinant modular protein vectors may be suitable for in vivo gene therapy, and Cu/Zn SOD should be considered as an interesting therapeutic transgene.

[1]  M. Goldberg,et al.  Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[2]  W. Pardridge,et al.  Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter. , 2004, Human gene therapy.

[3]  C. Epstein,et al.  Cold‐induced brain edema and infarction are reduced in transgenic mice overexpressing CuZn‐Superoxide dismutase , 1991, Annals of neurology.

[4]  M. Ebadi.  Biochemical alteration of a metallothionein-like protein in developing rat brain , 1986, Biological Trace Element Research.

[5]  C. Epstein,et al.  Brain Injury after Perinatal Hypoxia-Ischemia Is Exacerbated in Copper/Zinc Superoxide Dismutase Transgenic Mice , 1996, Pediatric Research.

[6]  D. Ferriero,et al.  Age-dependent differences in glutathione peroxidase activity after traumatic brain injury. , 2003, Journal of neurotrauma.

[7]  A. Villaverde,et al.  Molecular organization of protein-DNA complexes for cell-targeted DNA delivery. , 2000, Biochemical and biophysical research communications.

[8]  J. Crapo,et al.  Extracellular superoxide dismutase deficiency worsens outcome from focal cerebral ischemia in the mouse , 1999, Neuroscience Letters.

[9]  C. Epstein,et al.  Copper/zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after perinatal hypoxia ischemia , 1998, Annals of neurology.

[10]  D. Borchelt,et al.  Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[11]  B. Baxt,et al.  Foot-and-Mouth Disease Virus Receptors: Comparison of Bovine αV Integrin Utilization by Type A and O Viruses , 2003, Journal of Virology.

[12]  M. Miller,et al.  Polyethylene glycol-conjugated superoxide dismutase in focal cerebral ischemia-reperfusion. , 1993, The American journal of physiology.

[13]  P. Brundin,et al.  Recent Advances on the Pathogenesis of Huntington's Disease , 1999, Experimental Neurology.

[14]  L. Barbeito,et al.  Nitric Oxide and Superoxide Contribute to Motor Neuron Apoptosis Induced by Trophic Factor Deprivation , 1998, The Journal of Neuroscience.

[15]  C. Epstein,et al.  Reduction of CuZn-Superoxide Dismutase Activity Exacerbates Neuronal Cell Injury and Edema Formation after Transient Focal Cerebral Ischemia , 1997, The Journal of Neuroscience.

[16]  J. Urenjak,et al.  Is high extracellular glutamate the key to excitotoxicity in traumatic brain injury? , 1997, Journal of neurotrauma.

[17]  B. Freeman,et al.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Villaverde,et al.  Exploiting viral cell-targeting abilities in a single polypeptide, non-infectious, recombinant vehicle for integrin-mediated DNA delivery and gene expression. , 2000, Biotechnology and bioengineering.

[19]  B. Freeman,et al.  Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. , 1991, The Journal of biological chemistry.

[20]  J. Connor,et al.  Changes in iron histochemistry after hypoxic‐ischemic brain injury in the neonatal rat , 1999, Journal of neuroscience research.

[21]  J. Borg,et al.  Copper/zinc superoxide dismutase overexpression promotes survival of cortical neurons exposed to neurotoxins in vitro , 2002, Journal of neuroscience research.

[22]  S. Snyder,et al.  Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  E. Gahtan,et al.  Reversible impairment of long‐term potentiation in transgenic Cu/Zn‐SOD mice , 1998, The European journal of neuroscience.

[24]  Joseph Loscalzo,et al.  A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds , 1993, Nature.

[25]  P. Sinet,et al.  Age-related changes in antioxidant enzymes and lipid peroxidation in brains of control and transgenic mice overexpressing copper-zinc superoxide dismutase. , 1992, Mutation research.

[26]  C. Epstein,et al.  Attenuation of acute and chronic damage following traumatic brain injury in copper, zinc-superoxide dismutase transgenic mice. , 1996, Journal of neurosurgery.

[27]  L. Acarín,et al.  Microglial response to N‐methyl‐D‐aspartate‐mediated excitotoxicity in the immature rat brain , 1996, The Journal of comparative neurology.

[28]  K. Kogure,et al.  An immunohistochemical study of copper/zinc superoxide dismutase and manganese superoxide dismutase in rat hippocampus after transient cerebral ischemia , 1993, Brain Research.

[29]  L. Barbeito,et al.  Liposome-delivered superoxide dismutase prevents nitric oxide-dependent motor neuron death induced by trophic factor withdrawal. , 2000, Free radical biology & medicine.

[30]  P. Clarke,et al.  Kainate‐induced endocytosis in retinal amacrine cells , 2003, The Journal of comparative neurology.

[31]  J. Bockaert,et al.  NMDA-dependent superoxide production and neurotoxicity , 1993, Nature.

[32]  N. Bessis,et al.  Immune responses to gene therapy vectors: influence on vector function and effector mechanisms , 2004, Gene therapy.

[33]  M. Moskowitz,et al.  Pathobiology of ischaemic stroke: an integrated view , 1999, Trends in Neurosciences.

[34]  M. Asanuma,et al.  Regional Differences in Late-Onset Iron Deposition, Ferritin, Transferrin, Astrocyte Proliferation, and Microglial Activation after Transient Forebrain Ischemia in Rat Brain , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  O. Vinogradova,et al.  Integrin Bidirectional Signaling: A Molecular View , 2004, PLoS biology.

[36]  L. Barbeito,et al.  Astroglial nitration after postnatal excitotoxic damage: correlation with nitric oxide sources, cytoskeletal, apoptotic and antioxidant proteins. , 2005, Journal of neurotrauma.

[37]  D. Ferriero.  Neonatal brain injury. , 2004, The New England journal of medicine.

[38]  J. Mallet,et al.  An adenovirus encoding CuZnSOD protects cultured striatal neurones against glutamate toxicity , 1996, Neuroreport.

[39]  I. Fridovich,et al.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). , 1969, The Journal of biological chemistry.

[40]  C. Epstein,et al.  Reduced neurotoxicity in transgenic mice overexpressing human copper-zinc-superoxide dismutase. , 1990, Stroke.

[41]  A. Villaverde,et al.  Nonviral gene delivery to the central nervous system based on a novel integrin-targeting multifunctional protein. , 2003, Human gene therapy.

[42]  J. Borowitz,et al.  NMDA Receptor Activation Produces Concurrent Generation of Nitric Oxide and Reactive Oxygen Species: Implications for Cell Death , 1995, Journal of neurochemistry.

[43]  R. Giffard,et al.  Overexpression of copper/zinc superoxide dismutase decreases ischemia-like astrocyte injury. , 2005, Free radical biology & medicine.

[44]  R. Swanson,et al.  Differing Effects of Copper, Zinc Superoxide Dismutase Overexpression on Neurotoxicity Elicited by Nitric Oxide, Reactive Oxygen Species, and Excitotoxins , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[45]  L. Barbeito,et al.  Peroxynitrite triggers a phenotypic transformation in spinal cord astrocytes that induces motor neuron apoptosis , 2002, Journal of neuroscience research.

[46]  L. Acarín,et al.  Primary cortical glial reaction versus secondary thalamic glial response in the excitotoxically injured young brain: Microglial/macrophage response and major histocompatibility complex class I and II expression , 1999, Neuroscience.

[47]  M. Gurney,et al.  Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS) , 1995, Brain Research.

[48]  J. Hornung,et al.  N‐methyl‐d‐aspartate‐triggered neuronal death in organotypic hippocampal cultures is endocytic, autophagic and mediated by the c‐Jun N‐terminal kinase pathway , 2003, The European journal of neuroscience.

[49]  C. Cotman,et al.  Apoptosis Decision Cascades and Neuronal Degeneration in Alzheimer’s Disease , 1998, Neurobiology of Aging.

[50]  J. Holstege,et al.  Human Cu/Zn Superoxide Dismutase (SOD1) Overexpression in Mice Causes Mitochondrial Vacuolization, Axonal Degeneration, and Premature Motoneuron Death and Accelerates Motoneuron Disease in Mice Expressing a Familial Amyotrophic Lateral Sclerosis Mutant SOD1 , 2000, Neurobiology of Disease.

[51]  G. Bing,et al.  Changes of hippocampal Cu/Zn-superoxide dismutase after kainate treatment in the rat , 2000, Brain Research.

[52]  C. Tohyama,et al.  Localization of metallothionein in the brain of rat and mouse. , 1992, Journal of Histochemistry and Cytochemistry.

[53]  M. Faiz,et al.  Cu/Zn superoxide dismutase expression in the postnatal rat brain following an excitotoxic injury , 2005, Journal of Neuroinflammation.

[54]  M. Duchen,et al.  Exploration of the role of reactive oxygen species in glutamate neurotoxicity in rat hippocampal neurones in culture , 2001, The Journal of physiology.

[55]  K. Leong,et al.  New polyphosphoramidate with a spermidine side chain as a gene carrier. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[56]  U. Ungerstedt,et al.  Supersensitivity to apomorphine following destruction of the ascending dopamine neurons: quantification using the rotational model. , 1977, European journal of pharmacology.

[57]  D. Ferriero,et al.  Manipulation of Antioxidant Pathways in Neonatal Murine Brain , 2004, Pediatric Research.

[58]  P. Jenner,et al.  Understanding cell death in parkinson's disease , 1998, Annals of neurology.

[59]  W. Pardridge,et al.  Noninvasive gene targeting to the brain. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[60]  A. Villaverde,et al.  Engineering nuclear localization signals in modular protein vehicles for gene therapy. , 2003, Biochemical and biophysical research communications.

[61]  R. Sapolsky,et al.  Gene therapy against neurological insults: sparing neurons versus sparing function , 2001, Trends in Neurosciences.

[62]  M. Johnston,et al.  Mechanisms of Hypoxic Neurodegeneration in the Developing Brain , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[63]  J. Olney,et al.  Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[64]  L. Acarín,et al.  Expression of inducible nitric oxide synthase and cyclooxygenase‐2 after excitotoxic damage to the immature rat brain , 2002, Journal of neuroscience research.

[65]  Rafael Radi,et al.  Nitric oxide, oxidants, and protein tyrosine nitration , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[66]  L. Barbeito,et al.  Induction of motor neuron apoptosis by free 3‐nitro‐l‐tyrosine , 2004, Journal of neurochemistry.

[67]  A. Villaverde,et al.  Modular protein engineering for non-viral gene therapy. , 2004, Trends in biotechnology.

[68]  J. Olney.  Excitotoxin-mediated neuron death in youth and old age. , 1990, Progress in brain research.

[69]  Yves Garnier,et al.  Pathophysiology of perinatal brain damage , 1999, Brain Research Reviews.

[70]  Juan-Juan Xiang,et al.  IONP‐PLL: a novel non‐viral vector for efficient gene delivery , 2003, The journal of gene medicine.

[71]  Denis Gris,et al.  Transient Blockade of the CD11d/CD18 Integrin Reduces Secondary Damage after Spinal Cord Injury, Improving Sensory, Autonomic, and Motor Function , 2004, The Journal of Neuroscience.

[72]  Dan Sapoznikov,et al.  Down's syndrome: Abnormal neuromuscular junction in tongue of transgenic mice with elevated levels of human Cu/Zn-superoxide dismutase , 1988, Cell.

[73]  L. Schmued,et al.  Fluoro-Jade: Novel Fluorochromes for Detecting Toxicant-Induced Neuronal Degeneration , 2000, Toxicologic pathology.

[74]  M. Johnston,et al.  Neurotoxicity ofN-methyl-d-aspartate is markedly enhanced in developing rat central nervous system , 1988, Brain Research.

[75]  P. Kochanek,et al.  Effects of post‐injury hypothermia and nerve growth factor infusion on antioxidant enzyme activity in the rat: implications for clinical therapies , 2004, Journal of neurochemistry.

[76]  Jun Chen,et al.  Human Copper‐Zinc Superoxide Dismutase Transgenic Mice Are Highly Resistant to Reperfusion Injury After Focal Cerebral Ischemia , 1994, Stroke.

[77]  D. Busija,et al.  Neuroprotection against hypoxia-ischemia in neonatal rat brain by novel superoxide dismutase mimetics , 2003, Neuroscience Letters.

[78]  H. Federoff,et al.  Safety of viral vectors for neurological gene therapies. , 2004, Current opinion in molecular therapeutics.

[79]  R. Swanson,et al.  Astrocytes overexpressing Cu,Zn superoxide dismutase have increased resistance to oxidative injury , 2001, Glia.